Century Therapeutics Inc Cash Flow-to-Debt Ratio
Century Therapeutics Inc cash flow-to-debt ratio. Century Therapeutics Inc (IPSC) has a Cash Flow-to-Debt Ratio of -0.36x as of June 2026, meaning its operating cash flow of $-19.85 Million could theoretically repay 0% of its total liabilities ($54.66 Million) in one year. Check Century Therapeutics Inc (IPSC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Century Therapeutics Inc (2015–2025)
Cash flow-to-debt ratio of Century Therapeutics Inc from 2015 to 2025. Historical debt coverage capacity for Century Therapeutics Inc across 8 annual periods. Check how aggressively does Century Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Century Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2015–2025)
Century Therapeutics Inc cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Century Therapeutics Inc. For the full cash flow conversion analysis, see Century Therapeutics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.60x | $-103.88 Million | $64.77 Million | ▼ -179.4% |
| 2024 | -0.57x | $-110.14 Million | $191.85 Million | ▼ -14.3% |
| 2023 | -0.50x | $-88.35 Million | $175.94 Million | ▼ -756.8% |
| 2022 | 0.08x | $14.05 Million | $183.81 Million | ▲ +103.5% |
| 2021 | -2.16x | $-89.00 Million | $41.14 Million | ▼ -1017.7% |
| 2020 | -0.19x | $-41.27 Million | $213.19 Million | ▼ -118.8% |
| 2019 | -0.09x | $-16.17 Million | $182.75 Million | ▼ -141.1% |
| 2015 | 0.22x | $104.30 Million | $484.99 Million | — |